Skip to main content

Share story

Security Products

Bitget says attackers stole $351.6 million from exchange wallets

Bitget says attackers stole $351.6 million from exchange wallets Image: Primary
Cryptocurrency exchange Bitget says attackers stole $351.6 million from its hot and warm wallets after its systems detected unauthorized transfers at 18:31 UTC on September 24. The exchange temporarily suspended withdrawals while it investigates, though it says deposits and trading continue and customer balances remain accurate. Chief executive Gracy Chen said an attacker compromised a backend wallet system, spoofed transaction data and triggered the process that authorized transfers. She said the activity resembles known North Korean operations, but the intrusion method remains under investigation. Bitget says its cold wallets and separately operated self-custodial wallet were unaffected.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Hacker News and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.